Do you know?
Cancer risk increases with age. Unfortunately, over 70% of cancer cases are still diagnosed at late stages, often leading to more complex treatments and lower survival rates. However, advancements in medical technology now make it possible to detect cancer earlier, sometimes even before symptoms appear.
Powered by SPOT-MAS™ technology, this test can predict the presence and origin of up to 10 major cancers, including the top 5 most common cancers in Malaysia:
Breast
Lung
Colorectal
Stomach
Liver & biliary tract
Ovary
Pancreas
Oesophageal
Endometrial
Head & neck
Convenient
Only a single visit of blood draw is required for 10 main types of cancer.
Accurate
The test demonstrated high accuracy in identifying healthy (cancer-free) individuals, with a specificity of 99.8%, it correctly identified 99.8% of those without cancer (less likely to generate false positive results).
Efficient
Screens for multiple cancers in a single test while also complementing existing screening methods for a more comprehensive approach to early detection.
1. This promotion is valid from 26th May 2025 to 31st December 2025.
2. Includes hospital registration fee, MO consultation fee, and multi-cancer early detection test.
3. Excludes specialist consultation and other additional tests/medications/procedures (if any).
4. Applicable for self-pay customers only.
5. A ‘Patient Support Programme’ offering a RM2,000 subsidy is available for each patient who receives a positive result. It applies to confirmatory tests (eg. imaging, endoscopy) performed within 3 months of the result release dates.
6. Customers are required to make prior appointment for this promotion.
7. Beacon Hospital reserves all rights to change the terms & conditions without prior notice.
EN
中文
IDN
